YPYael Ganor Paz

Yael Ganor Paz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yael Ganor Paz has a total of 59 co-authors. Here are the top co-authors by number of shared publications:

  • Eran Barzilay

    Department of Obstetrics and Gynecology Samson Assuta Ashdod University Hospital Ashdod Israel

    2 shared publications
  • A. Berkovitz

    Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tshernichovsky Street, Kfar Saba, Israel

    1 shared publication
  • A. Hershko-Klement

    Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tshernichovsky Street, Kfar Saba, Israel

    1 shared publication
  • A. Shulman

    Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tshernichovsky Street, Kfar Saba, Israel

    1 shared publication
  • A. Wiser

    Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tshernichovsky Street, Kfar Saba, Israel

    1 shared publication
  • Adi Stern

    The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences Tel Aviv University Tel Aviv Israel

    1 shared publication

Latest Publications

  • Open Access

    AI Decision-Making Performance in Maternal–Fetal Medicine: Comparison of ChatGPT-4, Gemini, and Human Specialists in a Cross-Sectional Case-Based Study

    by Matan Friedman, Amit Slouk, Noa Gonen, Laura Guzy, Yael Ganor Paz, Kira Nahum Sacks, Amihai Rottenstreich, Eran Weiner, Ohad Gluck, Ilia Kleiner

    Background/Objectives: Large Language Models (LLMs), including ChatGPT-4 and Gemini, are increasingly incorporated into clinical care; however, their reliability within maternal–fetal medicine (MFM), a high-risk field in which diagnostic and management errors may affect both the pregnant patient and the fetus, remains uncertain. Evaluating the alignment of AI-generated case management recommendations with those of MFM specialists, emphasizing accuracy, agreement, and clinical relevancy. Study Design and Setting: Cross-sectional study with blinded online evaluation (November–December 2024); evaluators were blinded to responder identity (AI vs. human), and case order and response labels were randomized for each evaluator using a computer-generated sequence to reduce order and identification bias. Methods: Twenty hypothetical MFM cases were constructed, allowing standardized presentation of complex scenarios without patient-identifiable data and enabling consistent comparison of AI-generated and human specialist recommendations. Responses were generated by ChatGPT-4, Gemini, and three MFM specialists, then assessed by 22 blinded board-certified MFM evaluators using a 10-point Likert scale. Agreement was measured with Spearman’s rho (ρ) and Cohen’s (κ); accuracy differences were measured with Wilcoxon signed-rank tests. Results: ChatGPT-4 exhibited moderate alignment (mean 6.6 ± 2.95; ρ = 0.408; κ = 0.232, p < 0.001), performing well in routine, guideline-driven scenarios (e.g., term oligohydramnios, well-controlled gestational hypertension, GDMA1). Gemini scored 7.0 ± 2.64, demonstrating effectively no consistent inter-rater agreement (κ = −0.024, p = 0.352), indicating that although mean scores were slightly higher, evaluators varied widely in how they judged individual Gemini responses. No significant difference was found between ChatGPT-4 and clinicians in median accuracy scores (Wilcoxon p = 0.18), while Gemini showed significantly lower accuracy (p < 0.01). Model performance varied primarily by case complexity: agreement was higher in straightforward, guideline-based scenarios and more variable in complex cases, whereas no consistent pattern was observed by gestational age or specific clinical domain across the 20 cases. Conclusions: AI shows promise in routine MFM decision-making but remains constrained in complex cases, where models sometimes under-prioritize maternal–fetal risk trade-offs or incompletely address alternative management pathways, warranting cautious integration into clinical practice. Generalizability is limited by the small number of simulated cases and the use of hypothetical vignettes rather than real-world clinical encounters.


  • Feasibility of Fetal Proximal Lateral Cerebral Ventricle Measurement

    by Yael Ganor Paz, Denis Levinsky, Hadar Rosen, Eran Barzilay

    Objectives: Measuring the posterior horn of the lateral ventricle in the fetus during ultrasound scans may be challenging. We aimed to examine this measurement feasibility, in relation to gestational age.Methods: A cross‐sectional study was conducted, including nonanomalous fetuses, in which both lateral ventricles measured less than 10 mm during anomaly scans. The measurements were performed according to the International Society of Ultrasound in Obstetrics and Gynecology guidelines. Success rate of measuring both ventricles was assessed at different gestational ages. Association between lateral ventricle width with contralateral ventricle width, gender, gestational age, and fetal head position were assessed.Results: A total of 156 cases were recruited. The lateral ventricle distal to the probe was measured in all cases. In 10 cases proximal lateral ventricle could not be adequately measured (failed proximal ventricle measurement group). In 146 scans both ventricle measurements were available. All 10 cases of failed proximal ventricle measurement were in third trimester (30–38 weeks). Success rate of measurement of both ventricles was 100%, 96.2%, 71.4%, and 37.5% for gestational week 14–29, 30–32, 33–35, and 36–38, respectively (P <.001). Proximal lateral ventricle width was strongly associated with the distal ventricle width (B = 0.422, 95% confidence interval 0.29, 0.555, P <.001), but not with head position, fetal gender, or gestational age.Conclusions: Measurement of the proximal lateral ventricle is feasible in most cases, even during late third trimester scans. Efforts should be made to visualize both ventricles in every evaluation of the fetal brain.


  • Association of the Cerebro‐Placental Ratio With Adverse Outcomes in Pregnancies Affected by Gestational Diabetes Mellitus

    by Yael Ganor Paz, Eran Barzilay, Suraya Saied Idriss, Beth Murray‐Davis, Nir Melamed, Joel Ray, Michael Geary, Sarah McDonald, Jon Barrett, Karizma Mawjee Ma, et al.

    Objectives: Cerebro‐placental ratio (CPR) is a doppler tool contributes to clinical decision‐making in pregnancies affected by small for gestational age weight (SGA). Pregnancies affected by gestational diabetes mellitus (GDM) tend to have higher newborn weight, but greater risk of adverse perinatal outcomes. We hypothesized that in GDM‐complicated‐pregnancies CPR will be associated with adverse perinatal outcomes even in the absence of SGA.Methods: This prospective single‐center cohort study included non‐anomalous singleton pregnancies in women with GDM. Those with pre‐pregnancy diabetes mellitus, hypertensive disorder or suspected SGA were excluded. Routine fetal sonographic assessment included CPR—defined as middle cerebral artery pulsatilty index/umbilical artery pulsatilty index. Masked CPR measurement closest to birth was used, classified as >10th (normal) or ≤10th centile (low). Primary outcome was a composite, consisting of stillbirth, Caesarean birth due to abnormal fetal heart rate pattern, 5‐minute Apgar 24 hours.Results: Of 281 participants, 24 (8.5%) had low CPR, at a mean gestational age of 36.3 weeks (IQR 34.0–37.4). Birthweight percentile was significantly lower among the low CPR group (35th [IQR 16–31] versus 60th [IQR 31–82]; P = .002). There was no statistically difference in the primary composite outcome between the groups (8.3% versus 7.0%, P = .68). Low CPR was significantly associated with a higher risk of neonatal hypoglycemia (adjusted odds ratio 3.2, 95% CI 1.2–8.3).Conclusion: In pregnancies affected by GDM, CPR ≤10th percentile was not associated with adverse perinatal outcome but was associated with neonatal hypoglycemia.


  • Open Access

    Exposure to an informative video before planned Cesarean-delivery and maternal anxiety-a multicenter randomized controlled trial

    by Hadas Miremberg, Karen Yirmiya, Dana Vinter, Roy Lauterbach, Enav Yefet, Rima Nassra, Yael Ganor Paz, Rina Hagege, Michal Kovo, Eran Weiner


  • The association between SARS‐CoV‐2 infection and late pregnancy loss

    by Yael Ganor Paz, Sivan Shiloh, Tal Brosh‐Nissimov, Daniel Grupel, Nadav Sorek, Talia Kustin, Adi Stern, Marina Maklakovsky, Mia Polak, Merav Sharvit, et al.


  • Endometrial and Myometrial Multidimensional Growth During the Cycle

    by Yael Ganor-Paz, Rivka Sukenik Halevy, Adrian Shulman, Ronnie Tepper

    Three-dimensional sonography enables assessment of uterine morphology. While the pattern of endometrial growth has been well described, little information is available on changes in endometrial and myometrial volume, area, and perimeters. We evaluated the ratio between myometrial and endometrial dimensions and its relation to endometrial thickness of inpatients with normal uterine morphology from our hospital. Routine hormonal assessment on the day of the sonographic exam was extracted from electronic medical records. Correlations between different dimensions of the uterus were examined. A total of 38 3D sonographic data sets were reviewed. A significant correlation was found between estradiol blood levels and endometrial thickness, area, and volume (R = 0.35, 0.53, 0.55, respectively; P < .05). The ratio between the endometrial and myometrial area remained constant regardless of endometrial thickness. The findings of this study suggest that endometrial thickness, area, and volume may correlate with circulating estradiol levels. Endometrial and myometrial changes correlated in more than one dimension.

  • Vaginal examination vs. cervical length – which is superior in predicting preterm birth?

    by Merav Sharvit, Reut Weiss, Yael Ganor Paz, Keren Tzadikevitch Geffen, Netanella Danielli Miller, Tal Biron-Shental

    Objective: To compare the predictive value of preterm birth (PTB) by transvaginal sonographic cervical length (CL) measurement to digital examination of the cervix (Bishop score – BS), in patients with premature contractions (PC) and intact membranes.Design: A retrospective case-control study.Setting: Meir Medical Center, Kfar Saba, Israel.Population: Women at 24–34 weeks of gestation who were hospitalized with PC and intact membranes.Methods: All patients underwent CL and BS measurements upon admission. Power analysis revealed that 375 patients were needed to show a significant difference between the two methods for predicting PTB. Each one served as her own control.Main outcome measures: PTB<37 and<34 weeks.Results: Receiver-operator characteristic curve (ROC) and logistic regression analyses indicated a correlation between both shortened CL and increased BS to PTB (P<0.001). Neither test offered an advantage in predicting PTB. Areas under the curve for BS and CL ROC were similar for PTB before 37 weeks gestation (0.611 vs. 0.640, P=0.28). For nulliparous women, CL predicted PTB better that BS (0.642 vs. 0.724, P=0.03). For singleton and multiple pregnancy pregnancies, BS and CL did not differ significantly in predicting PTB (P=0.9, P=0.2, respectively). For nulliparous with multiple pregnancy, the BS and CL ROC curves differ nearly significantly (0.554 vs. 0.709, P=0.07), with better predictive ability for CL.Conclusions: CL and BS have similar value in predicting PTB in patients with PC. For nulliparous women, CL is superior over the BS.


  • What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation

    by Y. Ganor-Paz, Y. Friedler-Mashiach, Y. Ghetler, A. Hershko-Klement, A. Berkovitz, O. Gonen, A. Shulman, A. Wiser

    To evaluate whether high LH/FSH ratio has a clinical impact on patients with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF) with GnRH-agonist/antagonist protocols or in vitro maturation (IVM) treatments. We retrospectively reviewed all PCOS patients with day 3 LH/FSH ratio ≥1.5 who underwent IVF or IVM. The main outcomes measures were embryo quality and pregnancy rate. A total of 75 cycles were included. Among these, 44 patients underwent long agonist protocol, 16 antagonist protocol and 15 IVM. Age, basal LH and FSH levels, as well as duration of infertility were comparable for all groups. The LH level on the day of hCG administration was significantly lower in the antagonist group (0.9 IU/ml) compared to the long agonist group (1.4 IU/ml, p = 0.01). There was no difference in pregnancy rates among the groups: 27.2 % in the long agonist group, 37.5 % in the antagonist group and 26.6 % among the IVM patients. High LH/FSH ratio had no adverse effect on pregnancy rates in all three treatment modes.